Sarepta Therapeutics Inc. (NASDAQ:SRPT) Releases Update On SRP-9001 Gene Therapy Program...

Max - 0

Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) To Be Evaluated In RECOVERY Phase 3...

Max - 0

Seattle Genetics Inc. (NASDAQ:SGEN) Enters Two Oncology Collaboration Agreements With Merck...

Max - 0

AVEO Oncology (NASDAQ:AVEO) Announce Publication Of Phase 3 TIVO-3 Study Data...

Max - 0

Time Again for Covid Stocks? (LAKE, ALST, APT, DGX)

Max - 0

Genmab’s (NASDAQ:GMAB) Licensing Partner, Jansen Biotech Submits sBLA For DARZALEX FASPRO™...

Max - 0

InflaRx (NASDAQ:IFRX) Commence Phase III Study Of IFX-1 In Treatment Of...

Max - 0

CMS Grants NTAP For Nabriva Therapeutics PLC (NASDAQ:NBRV)’s XENLETA For Injection

Max - 0

Fortress Biotech Inc. (NASDAQ:FBIO) Announce Commencement Of Phase 3 CAEL-101 Studies...

Max - 0

FDA Accepts Ardelyx Inc.’s (NASDAQ:ARDX) NDA Filing For Tenapanor in Controlling...

Max - 0
1...187188189...248Page 188 of 248